October 15, 2019 - Page 19 of 21

NASDAQ Companies - October 15, 2019

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

BRIDGEWATER, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]

NASDAQ Companies - October 15, 2019

CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology

– CRISPR Therapeutics to receive non-exclusive access to certain KSQ IP for its allogeneic CAR-T programs –– KSQ Therapeutics to […]

NASDAQ Companies - October 15, 2019

Nabriva to Present Data at the CHEST Annual Meeting Demonstrating the Safety and Efficacy of Newly FDA-Approved XENLETA (lefamulin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

DUBLIN, Ireland, Oct. 15, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]

NASDAQ Companies - October 15, 2019

Interpace Named to ‘Most Admired Companies’ List

PARSIPPANY, NJ, Oct. 15, 2019 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has been […]

NYSE Companies - October 15, 2019

MVC Capital Declares Fourth Quarter 2019 Dividend

PURCHASE, N.Y., Oct. 15, 2019 (GLOBE NEWSWIRE) — MVC Capital, Inc. (NYSE:MVC), a publicly traded business development company that makes private […]

NYSE Companies - October 15, 2019

Comstock Mining Lucerne Closing Update

VIRGINIA CITY, Nev., Oct. 15, 2019 (GLOBE NEWSWIRE) — Comstock Mining Inc. (“Comstock”) (NYSE American: LODE) announced today that it […]

NYSE Companies - October 15, 2019

Burlington Stores, Inc. Appoints John Crimmins as Chief Financial Officer

BURLINGTON, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, […]

NASDAQ Companies - October 15, 2019

Affimed Reports Progress on Key Clinical Development Programs

IND application submitted for first-in-human study of AFM24, a bispecific EGFR/CD16A innate cell engager for solid tumorsFDA clearance of IND […]

TSX News - October 15, 2019

Erdene Announces C$8 Million Financing Package Led by the European Bank for Reconstruction and Development

HALIFAX, Nova Scotia, Oct. 15, 2019 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene” or the “Company“) is […]

NYSE Companies - October 15, 2019

Colfax Schedules Third Quarter 2019 Earnings Release and Conference Call

Annapolis Junction, MD, Oct. 15, 2019 (GLOBE NEWSWIRE) — Colfax Corporation (“Colfax”) (NYSE: CFX), a leading diversified technology company, today […]